跳至主要内容
临床试验/CTRI/2020/07/026645
CTRI/2020/07/026645招募中不适用

A Retrospective study on cancer patients attending Ayothidoss pandithar hospital, National Institute of Siddha,Chennai-600047

Ayothidoss Pandithar Hospital1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2020年7月24日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,000
试验地点
1
主要终点
Primary outcome will be assessed by no of cases treated in siddha medication,Patients with any type of cancer are most frequently turning to siddha medicine.

研究概览

简要总结

A  hospital based Observational Retrospective study conducted on 2000 cancer patients data  will be collected  based on inclusion and exclusion criteria. This study was approval Institutional Ethical Committee and number is NIS/IEC/2019/2, dated on 13/09/2019. Data collection based on Tamilnadu cancer Registration form such as Demographic details,Grade of cancer,Types of cancer,Treatment mortalites.  To observe incidence/prevalence of cancer and types of cancer. To study the reason of patient’s preference to Siddha treatment. Finally collect the data and analysis will be carried through statistical analytical method.The result of all statistical data findings will be published in the paper UGC approved and indexed peer reviewed journal.

研究设计

研究类型
Observational

入排标准

年龄范围
2.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients of confirmed diagnosis by oncologist reports.
  • 2.All cancer patients approaching for Siddha treatment at NIS-OPD.

排除标准

  • 1.Patients of not confirmed diagnosis by oncologist reports.

结局指标

主要结局

Primary outcome will be assessed by no of cases treated in siddha medication,Patients with any type of cancer are most frequently turning to siddha medicine.

时间窗: 6 months

次要结局

  • Secondary outcome will be assessed by incidence/prevalence of cancer,types of cancer,the reason of patients preference to siddha treatment,type of treatment and mortality.(6 months)

研究者

发起方
Ayothidoss Pandithar Hospital
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验